Epigenetic Silencing of miR-218-5p Modulates BIRC5 and DDX21 Expression to Promote Colorectal Cancer Progression
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094146 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Hibah Shaath und 3 weiteren Autor:innen. Beteiligte Einrichtung: Translational Oncology Research Center (TORC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF)…. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms, Survivin, DEAD-box RNA Helicases. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar Biomedical Research Institute.
Abstract (Originalsprache)
Colorectal cancer remains one of the leading causes of cancer-related deaths globally. Non-protein coding RNAs, including microRNAs, have emerged as crucial regulators in cancer progression. Herein, we analyzed publicly available datasets for miRNA expression in healthy controls, adenomatous polyps, and colorectal cancer and identified their regulatory networks using HCT116 and HT-29 CRC models. Differentially expressed miRNAs in adenomatous polyps and colorectal cancer were identified, highlighting their role in colorectal cancer initiation and progression. Notably, miR-218-5p was significantly downregulated in adenomatous polyps and colorectal cancer, suggesting a role in colorectal cancer initiation. Functional investigations revealed a tumor suppressive role for miR-218-5p in HCT116 and HT-29 CRC cell models, affecting cell proliferation and three-dimensional organoid formation and promoting cell death. RNA-Seq and bioinformatics identified BIRC5 and DDX21 as bona fide gene targets for miR-218-5p, validated by reverse transcription quantitative PCR and Western blotting. Further investigation into the genomic location of miR-218-5p, embedded within the SLIT2 and SLIT3 introns on chromosome 4 and chromosome 5, respectively, revealed epigenetic silencing through promoter hypermethylation in colorectal cancer cell models. These findings highlight epigenetic silencing of miR-218-5p in colorectal cancer, suggesting its potential as a biomarker and therapeutic target for early detection and intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Oncology Research Center (TORC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha P.O. Box 34110, Qatar.
- Genomics Core Facility, Hamad Bin Khalifa University, Qatar Foundation (QF), Doha P.O. Box 34110, Qatar.
- College of Health & Life Sciences, Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha P.O. Box 34110, Qatar.
ORCID-Profile: Khalid Ouararhni, Nehad M Alajez
Förderung
- Qatar Biomedical Research Institute
Zitieren
APA
Shaath, H., Vishnubalaji, R., Ouararhni, K., & Alajez, N. M. (2025). Epigenetic Silencing of miR-218-5p Modulates BIRC5 and DDX21 Expression to Promote Colorectal Cancer Progression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094146
Vancouver
Shaath H, Vishnubalaji R, Ouararhni K, Alajez NM. Epigenetic Silencing of miR-218-5p Modulates BIRC5 and DDX21 Expression to Promote Colorectal Cancer Progression. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094146
BibTeX
@article{Shaath2025,
author = {Shaath, Hibah and Vishnubalaji, Radhakrishnan and Ouararhni, Khalid and Alajez, Nehad M},
title = {Epigenetic Silencing of miR-218-5p Modulates BIRC5 and DDX21 Expression to Promote Colorectal Cancer Progression},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094146}
}
EUVIMED